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Abstract 
Integrins are heterodimeric cell surface adhesion receptors that play a critical role in 
tissue development. Characterization of the full length mRNA encoding the ȕ1 
subunit (Itgb1) revealed an alternative functional cleavage and polyadenylation site 
that yields a new Itgb1 mRNA isoform, 578bp shorter than that previously reported. 
Using a variety of experimental and bioinformatic approaches, we found that the two 
Itgb1 isoforms are expressed at different levels in a variety of mouse tissues, 
including the mammary gland, where they are differentially regulated at successive 
developmental stages. The longer mRNA species is privileged during lactation, while 
the shorter is induced after weaning. In 3D cultures, where expression of Itgb1 protein 
is required for normal formation of acini, experimental blockade of the longer isoform 
induced enhanced expression of the shorter species that allowed normal 
morphological mammary differentiation. The short isoform lacks AU-rich motifs and 
miRNA target sequences that are potentially implicated in the regulation of mRNA 
stability and translation efficiency. We further determined that the AU binding protein 
HuR appears to selectively stabilize the longer isoform in the mammary gland. In 
summary, our data identify a new regulatory instance involved in the fine-tuning of 
Itgb1 expression during mammary gland development and function. 


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Introduction  
 The extracellular matrix (ECM) is a complex mixture of molecules that 
surrounds cells providing support and conveying a variety of signals. Cell adhesion to 
the ECM is mediated largely by integrins, which cluster with numerous cytoskeletal 
and signaling proteins at focal adhesions and focal complexes [1]. Integrins are 
heterodimers that control many signaling events, which are critical for cell survival, 
growth, and gene expression regulation [1, 2]. In mammals, the integrin family 
contains 18 E and 8 D subunits that form 24 distinct receptors with specific tissue 
distribution and function as shown by both their specificity for ECM ligands and 
knockout mouse phenotypes [2]. 
 
 The integrin E1 subunit (Itgb1) is found in 12 different integrins that bind to 
ECM protein ligands, namely collagen, laminin, fibronectin, tenascin C and 
vitronectin [3, 4]. E1 integrins are expressed in a wide variety of tissues. They are 
critical for the induction and maintenance of cell differentiation and are involved in 
tissue homeostasis and diverse physiological functions [3]. Knock-out studies in 
mouse models have revealed an essential role for E1 integrin in early development 
since genetic deletion resulted in embryonic lethality shortly after implantation [5, 6, 
7]. 
 In the mammary gland, interaction between epithelial cells and the ECM is 
required for tissue development and function. Particularly, E1 integrins play a critical 
role in the maintenance of mammary tissue structure and function [3]. These 
molecules are essential for control of cell survival and proliferation during mammary 
gland development, as well as for mammary epithelial cell differentiation [8, 9, 10].  
 By alternative mRNA processing (as inclusion or exclusion of specific exons, 
poly(A) tail length, etc.) transcripts with different characteristics are generated from 
the same gene. Different processing alternatives may influence localization, stability, 
transport and translation efficiency of the mRNAs. Such differences are likely to be 
highly influential in cell fate changes that impinge on tissue and organism 
development [11, 12]. Through alternative polyadenylation, a specific transcript has 
the potential to be cleaved and processed at alternative sites with the addition of a 
poly(A) tail (pA or poly(A) sites), resulting in mature mRNAs with 3´UTRs of 
different lengths. These non-coding regions influence both translation efficiency and 
mRNA stability. In some cases by the binding of specific proteins to well defined 
AU-rich sequences. These proteins are known as AUBPs (for AU-rich Binding 
Proteins). HuR, AUF1, KSRP and TTP are major representative members of this 
family [13]. 
 In the present study, we characterized the Itgb1 3’UTR and identified an 
alternative polyA site that, when utilized, results in a shorter Itgb1 mRNA isoform 
than that reported previously. This new isoform appears to lack functional regulatory 
sequences that modulate Itgb1 mRNA stability and translational efficiency in 
mammary cells.
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Materials and Methods  
Cell Culture 
 The HC11 cell line, derived from pregnant BALB/c mouse mammary glands, 
was maintained as previously described [14]. HeLaTetOff cells (Clontech, Madison, 
WI) were maintained in Dulbecco’s modified Eagle’s medium high glucose (DMEM) 
(Invitrogen, Grand Island, NY), with L-glutamine and sodium pyruvate supplemented 
with 10% fetal bovine serum and penicillin/streptomycin/amphotericin B (Invitro-gen, 
Grand Island, NY).
Cell Differentiation and Cell Stretching 
 
HC11 cell differentiation was induced as previously described [14]. To 
perform stretching assays, laboratory made silicone membranes, coated with collagen 
type I, were placed inside Petri dishes (60 mm diameter). Cells were plated at a 
density of 7 x 105 cells/dish. After attachment, they were grown for approximately 
48h, until the cell culture became confluent. Membranes with the attached cells were 
removed from the culture dishes and carefully placed inside the stretching device after 
which the unit was assembled as previously described [15].  Prewarmed serum-free 
cultura medium was added on top of the cells. Membranes were exposed to sustained 
radial strain of 20% for different time intervals (3h to 5h). Afterwards, mRNA 
extraction protocols were carried out as described below. 
Transient Transfections 
 
HC11 and HeLa-TetOff cells were plated in complete media and were allowed 
to grow overnight to 70–80% confluence. The cells were transfected using linear 
polyethylenimine/PEI (Polysciences, Warrington, PA) with a protocol adjusted for 
each cell line: 2, 4 or 10ȝg of total  DNA, for 6-well plates, 6-cm or 10-cm dishes 
respectively, were incubated in the presence of PEI (1ȝg/uL pH 7,2), in a 3:1 ratio 
(PEI:DNA) for both cell lines, in OptiMEM media (Invitrogen, Grand Island, NY) for 
10 minutes. RPMI or DMEM media, for HC11 and HeLaTetOff cells respectively, 
without serum was then added to the mixture. These complexes were added to the cell 
plates that were previously washed 3 times with PBS 1X. After 3 to 6 h cells were 
washed with PBS 1X and the transfection mixture was changed to growth medium. 
DNA Constructs 
 
The PCR fragment corresponding to the 3’UTR region present only in the 
short isoform (Itgb1 3’UTR Short) (NM_010578, bases 2719 to 3232) and the 
fragment corresponding to the differential region between the long and short isoforms 
(Itgb1 3’UTR D) (NM_010578, bases 3232 to 3810) were cloned downstream of the 
Luciferase gene in the pGL3 control plasmid using the Xba I restriction site. In 
addition, the Itgb1 3’UTR “D” fragment was cloned into the pTRE2hygLuc plasmid 
(Clontech, Madison, WI) using the Nhe I and Sal I restriction sites (pLuc Itgb1 
3’UTR D). A fragment containing the Itgb1 ARE1 region, plus 50 bp upstream and 
50 bp downstream, was cloned using the CloneJET™ PCR Cloning Kit from 
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Fermentas, to prepare probes for the RNA EMSA assays (pJET-Itgb1ARE1) by in 
vitro transcription. The same sequence was inserted in an inverted orientation in order 
to generate a suitable control for specificity (pJET-Itgb1ERA1). The cDNA of mouse 
HuR was subcloned into pCEFL-HA and pGEX4T3 (María Sol Degese et al, 
manuscript in preparation). The PAS1 region, flanked by a 200 bp sequence (00 bp 
upstream and 100 bp downstream), was cloned into the pRiG vector using the Xho I 
and BamHI restriction sites to build pRiG-Itgb1.pA1. Plasmids pRiG and pRiG-
77s.AE were kindly provided by Dr. Bin Tian (Univ. of New Jersey). Point mutations 
in the PAS1 region were introduced using the QuickChangeII site-Directed 
Mutagenesis Kit (Stratagene). The wild type PAS1 sequence (ATTAAAATAAA) 
was therefore mutated to the sequence AGTAAAAGGAA (pRiG-Itgb1.pA1mut). 
Real-time PCR 
 
Total cellular RNA was isolated using TriZol (Invitrogen, Grand Island, NY) 
or TriReagent (Genbiotech, Buenos Aires, Argentina) using the manufacturer’s 
protocols. mRNAs were reversetranscribed using oligo-dT primers (Promega, 
Madison, WI). Real-time quantitative PCR was performed using a Stratagene MX 
3000P QPCR with SYBR green (Roche, Basel, Switzerland) detection. For the real 
time PCR 2 ȝg of total RNA was subjected to reverse transcription. A 1 in 10 dilution 
of all samples was then used to measure the expression of the endogenous Itgb1 
isoforms relative to GAPDH expression. The following primers were utilized for the 
different Itgb1 mRNA isoforms: Itgb1-T forward (5’-CGTCGCAGCATATGAACC-
3’) reverse (5’-AACAAAGCCACCAGCAAGG-3’); Itgb1-S forward (5’-
GCAGCATCTGAACCAT-GAC-3’), reverse (5’-TTTTTTTTTTTTTTTTTGAAC-
3’); Itgb1-L forward (5’-AAACCTGTGT-GCCATTGTG-3’), reverse (5’-
GCCTTTATGTGAATAGTGCTAAG-3’). HuR: Forward (5'-
TGGGCTACGGTTTTGTG-3’), Reverse (5'-GGACCCTGGAGTTGATGATT-3’). 
 
Western blotting 
 
The protein extracts were collected from mammary gland tissues and cell 
lysates and homogenized in RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 
1% NP40, 0.5% sodium deoxycholate, 0.1% SDS) with protease and phosphatase 
inhibitors (Pierce, Rockford, IL). After heat denaturation, equal amounts of protein 
lysates, as previously determined by Bradford’s technique, were separated on 8% 
SDS-polyacrylamide gels and transferred to nitrocellulose membranes. The blots were 
blocked in 5% non-fat dry milk for 1 hour and incubated overnight with anti-Itgb1 
(1:600, sc-8978 M-106 Santa Cruz), anti-HuR (1:1000, sc-5261 3A2 Santa Cruz), 
anti-ciclin D1 (1:600, sc-8396 A-12 Santa Cruz) or anti-actin (1:2000, sc-1616 I-19 
Santa Cruz) at 4°C. After incubation with infrared-conjugated secondary antibodies, 
the membrane was scanned in an Odyssey SA scanner (LICOR Biosciences, Lincoln, 
NE), and band intensities were quantified using the Odyssey software. 
 
Morphogenesis assay 
 
HC11 cells were treated with trypsin and resuspended in growth medium. The 
cells were pelleted and resuspended in assay medium (RPMI supplemented with 2% 
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FBS, 2 mM L-glutamine, 2.5 ng/ml EGF and 5g/ml insulin) at a concentration of 
25,000 cells/ml. Eight chambered RS glass slides (Nalgene) were coated with 40 uL 
Matrigel basement membrane matrix per well and left to solidify for 15 min. The cells 
were mixed 1:1 with assay medium containing 4% Matrigel, and 400 uL was added to 
each chamber of the Matrigel-coated eight-chambered slide. Assay medium was 
replaced every 4 d.  
 
Indirect immunofluorescence and image acquisition 
  
 The following primary antibodies were used for indirect immunofluorescent 
detection of specific antigens: anti–cleaved caspase 3 (Asp175; Cell Signaling) and 
Anti-Laminin 5 antibody (ab78286; Abcam). All first antibodies were used at a 
dilution of 1:200. Secondary antibodies were as follows: anti-mouse or anti-rabbit 
coupled with Alexa Fluorescent dyes. All secondary antibodies were used at a dilution 
of 1:500. Nuclei were stained with DAPI. Confocal analyses were performed using 
confocal Olympus Fluoview FV 1000 microscope.
 
shRNA knockdown of Itgb1 expression 
 
Itgb1 mouse shRNA (OligoIDs: V2LMM_39157, V3LMM_429938, 
V2LMM_188403) and Non-silencing-GIPZ lentiviral shRNAmir control (RHS4348) 
clones were obtained in pGIPZ-GFP vectors (Thermo Scientific Open Biosystems, 
Huntsville, AL) and transfected into HC11 cells using PEI. Four stable cell lines were 
generated: Sh Itgb1-T, Sh Itgb1-L and Sh control. The knockdown of Itgb1 
expression was analyzed by western blot. 
 
siRNA Knockdown of HuR expression 
 
HuR siRNA and AllStars Negative Control siRNA (QIAGEN) were 
introduced in HC11 cultured cells by cell transfection using Lipofectamine 2000 
(Invitrogen) according to the manufacturer's instructions at a concentration of 40 nM. 
The knockdown effects were analyzed 3 days after transfection by RT-qPCR and 
western blot as shown. 
 
Analysis of Reporter and Endogenous mRNA decay by Real Time PCR 
 
To measure reporter mRNA decay, HeLaTetOff cells (Clontech, Madison, 
WI) were transiently transfected using PEI reagent with each reporter construct: pLuc 
Itgb1 3’UTR D and pCEFL-HA-HuR. This cell line expresses the tTAS2 
transactivator that induces transcription in the absence of tetracycline or its analog 
doxycycline. After transfection, cells were incubated in tetracycline free media for 
24h, then tetracycline was added to a final concentration of 1 ȝg/ȝL, for a period from 
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0 to 5h. After this, cells were lysed and RNA was isolated following the 
manufacturer’s protocols as described above. 2ȝg of total RNA was treated with RQ1 
RNase free DNase (Promega, Madison, WI) for 15 minutes, followed by first strand 
cDNA synthesis using MMLV reverse transcriptase (Promega, Madison, WI), RNasin 
(Promega, Madison, WI) and OligodT (Biodynamics, Argentina). Luciferase mRNA 
was quantified by qPCR using the following primer set: Forward (5’-
CCGCCGTTGTTGTTTTG- 3’); Reverse (5’- ACACAACTCCTCCGCGC-3’). 
Luciferase mRNA expression was normalized against the hygromycin resistance gene 
product which is present in the reporter plasmid. Primer sequences were: Forward (5’-
GGAATCCCCGAACATCG-3’); Reverse (5’-GCAGACGCGCTACTTCG-3’). To 
measure endogenous Itgb1 mRNA, proliferating or differentiated HC11 cells were 
incubated with Actinomycin D to a final concentration of 5 ȝg/mL, for a period from 
0 to 5h cells and lysates were then analysed as described above. 
RNA Electrophoretic Mobility Shift Assays 
 
RNA probes were synthesized with a T7 RNA transcription Kit (Promega, 
Madison, WI) using the pJETItgb1ARE1 and pJET-Itgb1ERA1 plasmids. For 
radioactive probes [Į-32P]rUTP (NEN Perkin Elmer, Waltham, MA), was added. 
Total extracts were obtained from HC11 cells that had been plated on 6 well plates 
using growth conditions and from tissue samples derived from normal mouse 
mammary gland. Protocols for extraction and incubation have been previously 
described (16). Cells were washed with cold PBS 1X, and lysed with Lysing Buffer: 
10mM HEPES pH 7.6, 3mM MgCl2, 40 mM KCl, 2 mM DTT, 5 % glycerol, 0.5 % 
igepal, 1mM phenylmethylsulfonyl fluoride (PMSF), 10mM NaF, 1mM sodium 
orthovanadate, 10mM betaglycerophosphate, and protease inhibitor cocktail (Sigma). 
After centrifugation (5 minutes, 14000 rpm, 4°C) the protein concentration of each 
sample was measured using Bradford’s technique. 5ȝg of total protein was pre-
incubated with BSA (final concentration 500 ng/ȝL), tRNA (125 ng/ȝL) and heparin 
(10 ng/uL) for 5 minutes at room temperature (RT). 2-4 ng of radioactive probe was 
added to the mix followed by incubation at RT for 20 minutes. Finally single stranded 
(unbound) RNA was digested with 0.6 units of Rnase T1 incubated for 10 minutes 
RT. The ribonucleocomplexes were resolved on pre-run (20 min), 6% non-denaturing 
polyacrylamide gels with a TBE buffer system for 1.5 h. 
Bacterial Expression of GST Fusion Proteins 
 
The BL21 pLys E. coli strain was transformed with a construct based on the 
vector pGEX-4T3 encoding the fusión protein GST-mHuR WT by insertion of a 
DNA fragment containing the HuR open reading frame. Bacteria were grown in 500 
mL of LB medium until the optical density was 0.5, at which time isopropyl beta-D-
1-thiogalactopyranoside (1 mM final) was added for 3 h. Bacterial pellets were 
collected by centrifugation at 3000 g for 30 min and resuspended in 10 ml of PBS, 1% 
Triton X-100, 1 mM EDTA, 2 g/ml aprotinin, 2 g/mLleupeptin, and 1 mM PMSF. 
Suspensions were then sonicated and debris removed by centrifugation at 10,000 x g 
for 15 min. Supernatants were mixed with 300 ȝL of glutathione-agarose beads 
(Amersham Biosciences, Piscataway, NJ) and centrifuged at 3000 x g for 5 minutes. 
The pellet was washed three times with PBS, 1% Triton X-100, 1mM EDTA, 
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protease inhibitor cocktail (Sigma-Aldrich, Saint Louis, MO), and 1mM PMSF and 
then twice with PBS, protease inhibitor cocktail, and 1 mM PMSF. Finally, purified 
fusion proteins were eluted in 50 mM Tris, 10 mM glutathione, protease inhibitor 
cocktail, and 1 mM PMSF. 
Luciferase Reporter Assays 
 
HC11 cells were transiently transfected with each reporter construct using 
PEI. The amount of luciferase mRNA was quantified using the primers described 
above, and normalized relative to GAPDH: Forward (5’-
AAGAAGGTGGTGAAGCAGGCATC-3’), and Reverse (5’-
CGAAGGTGGAAGAGTGGGAG-TTG-3’). For luciferase activity assays, cells were 
seeded on 6-well or 12-well dishes and transfected with 0.1 ȝg of luciferase reporter 
vector and a vector that constitutively expresses betagalactosidase. Cells were lysed in 
passive lysis buffer (Promega, Madison, WI) 24h post-transfection. Cell lysates were 
incubated with luciferin reagent (luciferase Reporter System – Promega, Madison, 
WI). Data was normalized for efficiency of DNA transfection by measuring 
betagalactosidase activity. 
Animal treatments 
 
BALB/c mice were maintained in a pathogen-free, temperature controlled 
environment on a “12h light / 12h dark” cycle and given sterilized laboratory chow 
and water ad libitum in accordance with the standard international animal care 
protocols (Canadian Council of Animal Care’s 1980 Guide to the Care and Use of 
Experimental Animals). Animal procedures were carried out at the Animal Facility of 
the School of Sciences of the University of Buenos Aires (Facultad de Ciencias 
Exactas y Naturales, Universidad de Buenos Aires) following the guidelines provided 
by the University of Buenos Aires Institutional Animal Care and Use Committee, 
which oversees the university’s animal care and use program and is responsible for 
reviewing all animal use protocols (U.S. Public Health Service Approved Animal 
Welfare Assurance: A5801-01). The fourth mammary glands were aseptically 
removed from virgin, pregnant, lactating (7 d after delivery) and involuting (24h; 48h 
and 72h after weaning (pups were removed after 5–7 d of nursing)) females.  
FACS analysis 
 
HC11 cells grown in 6-well plates were transfected with different pRiG 
derived vectors. Cells were harvested 48h after transfection and were subjected to 
fluorescent activated cell sorting (FACS) analysis. Briefly, cells were treated with 
0.25 % trypsin solution to release them from culture dishes. Green and Red 
fluorescence were read at 530 nm and 585 nm, respectively, using the BD 
FACScalibur system (BD Biosciences, San José, CA). Transfection with a plasmid 
expressing EGFP alone was used to adjust the green fluorescence channel. The R 
program was used to draw the cumulative fraction curves, using codes for plotting as 
previously described [17]. 
Rapid Amplification of cDNA 3’ Ends (3’RACE-PCR) 
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The first strand cDNA synthesis was performed for 2h at 37°C on a reaction 
mixture containing 3ȝg of total RNA, 10 units of RNAsin (Promega Biotech, 
Madison, WI), 100U of reverse transcriptase (RT) (SuperScript, Gibco, Grand Island, 
NY), 1mM of DTT, 1X RT Buffer, 0.5mM of dNTPs and 1ȝg/ȝL of the adaptor 
primer Ad-(dT)15 (5’-GTCGCGAATTCGTCGACGCG-(dT15)-3’). PCR reactions 
were carried out using a specific forward primer for Itgb1 (Ex17: 5’-
AGAAAATGAATGCCAAGTGGG-3’) and the reverse primer Ad-(dT)15 as 
outlined in Figure 2. The products were analyzed on 0.7% agarose gels stained with 
ethidium bromide. After several restrictive PCR conditions, the fragments of interest 
were purified using the QIAquick Gel Extraction Kit (Qiagen, Germany), directly 
ligated into the pGEMT Easy Vector System (Promega, Madison, WI), and 
sequenced. The identities of the fragments were analyzed using public databases.  
 
EST and SAGE database mining 
 
Mouse ESTs corresponding to the Itgb1 transcript (Mm.263396) were 
downloaded from the UniGene database (http://www.ncbi.nlm. nih.gov/unigene) and 
comprised a total of 771 EST sequences. Two-hundred and eighty-three 3'-read ESTs 
with polyadenylation sites were extracted and aligned against the mouse Itgb1 gene 
using the BLASTN algorithm at NCBI. The EST end positions were mapped back to 
the genome location (NCBI37/mm9 assembly) using the UCSC genome browser 
resource (http://genome. ucsc.edu). To perform a comparative analysis of the mouse 
Itgb1 variants expressed in different mouse tissues, we analyzed 269 mSAGE 
libraries downloaded from the Cancer Genome Anatomy Project – SAGE Genie 
database (http://cgap.nci.nih.gov/SAGE/). SAGE tag counts were normalized to 
200,000 tags per library according to the total tag count in each library. Three reliable 
SAGE tags were found for Itgb1 transcripts: (5’-CCAGGGACTG-3’) (2877bp 
relative to the starting position of the NM_010578.2 sequence), (5’-ACTGATTTTC-
3’) (3051bp), and (5’-CTTGCTCTGT-3‘) (3706bp), among which (5’-
CTTGCTCTGT-3’) corresponded to the Itgb1-L variant, and (5’-CCAGGGACTG-
3’) and (5’ACTGATTTTC-3’) corresponded to the Itgb1-S variant. Expression values 
for both Itgb1-S tags were combined for statistical analysis. MultiExperiment Viewer 
software (MeVv4.7) was used to enable the visualization and illustration of our 
analyses [18]. This tool was employed for normalization and hierarchical clustering 
analysis of the SAGE data. 
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Results
Alternative cleavage and polyadenylation sites in the Itgb1 gene results in the 
expression of two mRNA isoforms 
Sequence analysis of the mouse Itgb1 gene identified two distinct poly(A) 
consensus sequences located in the 3’UTR which suggested the existence of 
alternative cleavage and polyadenylation sites. Our observation of 3'-read EST 
sequences confirmed the existence of two functional cleavage and polyadenylation 
sites in the Itgb1 gene and two clusters corresponding to the alternative polyA sites 
were identified (Figure 1A). It was determined that the longer isoform (Itgb1-L) 
represented approximately 92% (260 out of 283) and the Itgb1-S isoform 8% (23 out 
of 283) of the 3'-read Itgb1 EST sequences in the mouse. To verify the presence of the 
Itgb1 species in a greater variety of tissues, the 3'-read ESTs were further analyzed 
using Unigene annotations. The Itgb1-L variant predominated in brain, eye and heart 
libraries, where it represented 95-100% of total Itgb1 transcripts. In contrast, in the 
mammary gland, ovary and pancreas there was significant enrichment of the Itgb1-S 
species, which constituted 25-40% of all Itgb1 ESTs (Figure 1B). Similarly, using a 
publicly-available dataset of 269 mouse SAGE libraries, we determined that the 
Itgb1-L transcript is expressed at higher levels than the Itgb1-S in almost all libraries 
analyzed. Again, Itgb1-S was detected at consistently higher levels in mammary 
gland, urogenital and vascular endothelial tissues than in brain and eye (retina) tissues 
(Figures 1B and 1C). 
 
To experimentally confirm the presence of these alternative Itgb1 isoforms by 
PCR analysis, we designed specific primers that bind to the last exon of the mouse 
Itgb1 gene, encompassing the identified distinct poly(A) consensus sequences (PAS1 
and PAS2) and potential cleavage sites located in the 3’UTR (Figure 2A and 2B). The 
mammary gland was chosen to study the expression of the Itgb1 isoforms, because it 
allowed us to determine whether they can be developmentally regulated in the adult 
animal. Therefore, mouse mammary glands at different stages of development, as 
well as MMTV-induced mouse mammary tumors [19], were used as sources of 
mRNA. The 3’UTR regions of Itgb1 transcripts were isolated by 3’RACE PCR, 
producing 1400bp and 750bp amplicons (Figure 2B and 2C). Sequence analysis of the 
fragments confirmed the presence of the potentially functional poly(A) sites (Figure 
2D). The shortest 3’UTR corresponded to Itgb1-S and was composed of 578 
nucleotides, while the longer Itgb1-L 3’UTR was 1110 nucleotides in length. 
Interestingly, Itgb1-L sequence showed two ARE class I sequences, ATTTA (ARE1 
and ARE2, in Figure 2D and 2E) that were absent in the Itgb1-S variant.  
 
 
The proximal pA1 site in the 3’UTR of Itgb1 is fully functional 
 
To further confirm the functionality of the Itgb1 proximal polyadenylation site 
(pA1) in mammary cells, the pRiG vector was used. This reporter expresses a 
bicistronic transcript for two fluorescent proteins (RFP and EGFP) and includes a 
polylinker between the two open Reading frames (ORFs). When a functional site for 
cleavage and polyadenylation is inserted between the ORFs, the proportion of 
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expressed fluorescent proteins is altered. Then, mouse mammary HC11 cells were 
transfected with the different pRiG variants. In one of them, the 200 bp region 
surrounding PAS1 (see Figure 2D and 2E) wild type and mutated were introduced into 
the cloning site of this vector (Figure 3A, pRiGItgb1.pA1 and pRiG-Itgb1.pA1 mut) 
and expression of the fluorescent proteins were analyzed by flow cytometry. 
Expression of the pA1 construct (pRiG-Itgb1.pA1) showed a higher intensity of red 
fluorescence (RFP) than the empty vector (pRiG) or a pRiG construct containing a 
mutated pA1 element (Figure 3B). The EGFP/RFP cumulative fraction (Fig 3B lower 
panel) indicates that expression of pRiGItgb1.pA1 led to significantly lower 
EGFP/RFP ratios (P < 2.2E-16, Kolmogorov-Smirnov test), which demonstrates the 
functionality of the proximal Itgb1 cleavage site. Furthermore, the ratio between the 
percentage of events shown in the upper left quadrant (mostly red) to the lower right 
quadrant (mostly green) from four independent FACS analyses (Figure 3C) clearly 
shows that pA1 sequences are recognized by the cleavage and polyadenylation 
machinery of mammary epithelial cells, resulting in the production of a functional 
mRNA species. 
 
 
Expression pattern of Itgb1 isoforms during differentiation and involution of the 
mouse mammary gland 
 
 Analysis of Itgb1 protein expression in the mouse mammary gland (epithelium 
and stroma) at successive developmental stages showed an increase during pregnancy 
and lactation (Figure 4A). On the other hand, RT-qPCR assays revealed a reduction of 
Itgb1 mRNA levels during lactation, as previously reported [20] (Figure 4B). Then, 
using primers specially designed to amplify each Itgb1 mRNA isoform (see figures 
2D and 2E), we proceeded to evaluate whether each species showed a differential 
expression pattern during mammary gland differentiation and involution in adult 
female mice (Figures 4C and 4D). Here, is important to point out that despite the low 
complexity of the Itgb1-S reverse primer, amplification of this template resulted in a 
single specific product (data not shown). The analysis revealed that the ratio of 
mRNA expression for each Itgb1 isoform changes at different stages of development 
in mammary tissue. From virgin to lactating glands Itgb1-L mRNA levels show little 
variation, while Itgb1-S decreases to undetectable levels (Figre 4C). Alternatively, a 
strong increase of Itgb1-S expression was detected at 72 h of involution (Figure 4C 
and D). Interestingly, the application of a stretching protocol, which triggers 
involution-associated molecular events in HC11 mammary cells [15], also induced 
Itgb1-S and inhibited Itgb1-L expression in culture (Figure 4E). Taken together, these 
results suggest that although total Itgb1 mRNA expression might be reduced in the 
differentiated mammary gland, the longer isoform would be stabilized and efficiently 
translated during lactation. 
Biological relevance of the Itgb1-S isoform. 
 
The data reported above suggested to us that the Itgb1-L isoform prevails in 
the lactating mammary gland. In order to test whether expression of this species is 
required for mammary epithelial cell differentiation, we used a combination of 
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shRNA plasmids to block the expression of the Itgb1-L isoform specifically, or both 
species, Itgb1-L and S, together. The shItgb1-L was designed to bind a region 
between pA1 and pA2 (see Figure 5A) and, therefore, to reduce Itgb1L mRNA 
exclusively, without affecting Itgb1-S levels. On the other hand, shItgb1-T would 
bind sequences upstream to pA1, lowering the levels of both mRNA isoforms. We 
found that HC11 cells stably transfected with shItgb1-T show an important reduction 
of Itgb1 protein levels, while cells transfected with shItgb1-L show an intermediate 
level of Itgb1 protein. Interestingly, CiclinD1 levels, which are clearly reduced in 
cells transfected with shItgb1-T, are not affected by the shItgb1-L (Figure 5A). 
Analysis of mRNA expression by qPCR, show that both shRNAs have a similar 
detrimental effect on Itgb1-L expression; alternatively, expression of the Itgb1-S 
isoform is significantly increased when Itgb1-L is specifically targeted (Figure 5B). 
To analyze the effects of the Itgb1 shRNAs on morphological differentiation, 3D 
cultures of HC11 cells were performed by seeding the cells in Matrigel coated dishes. 
Figure 5C shows that the specific blockade of Itgb1L does not affect formation of 
acini that show characteristic features of differentiated structures including expression 
of cleaved caspase 3 in the interior and laminin V surrounding them (Supplementary 
Figure 1). Interestingly, HC11 cells transfected with shRNA-T also form acini, 
although they are reduced in size, number and show an altered morphology (Figure 
5C and Supplementary Figure 1).  These results indicate that Itgb1-L is not required 
per se for mammary gland differentiation, while a minimum of Itgb1 protein 
expression, which would be mostly translated from the Itgb1-S isoform in the 
shItgb1-L transfected cells, might be necessary for the epithelium to successfully 
complete morphological differentiation. 
 
Itgb1-L is specifically stabilized during mammary gland differentiation 
 
Figure 4 shows that Itgb1-S mRNA is significantly reduced during pregnancy 
and lactation, while not significant changes affected Itgb1-L levels. Therefore, we 
speculated that the longer isoform might be specifically stabilized during that period, 
allowing efficient expression of the Itgb1 protein. To examine this possibility we 
proceeded to analyze the stability of each Itgb1 isoform in proliferating and 
differentiated HC11 mammary cells [14]. Therefore, the level of both Itgb1 mRNA 
endogenous species remaining at specific times after the addition of the 
transcriptional inhibitor Actinomycin D was analyzed by qRT PCR in mRNA isolated 
from proliferating or differentiated cells. Figure 6A demonstrates that Itgb1-L mRNA 
is more stable in differentiated than in proliferating HC11 cells. In contrast, Itgb1-S 
was unstable under both conditions (Figure 6B). Figures 2D and 2E indicate                              
that Itgb1-L includes ARE sequences that are not present in the shorter isoform. 
Therefore, we postulated that stabilization of the longer isoform might be due in part 
to the presence of AUBPs that bind specifically to those sequences. Among the well-
characterized AUBPs, HuR has been described to have a stabilizing role on bound 
mRNAs [21]. Therefore, to determine whether this AUBP might stabilize Itgb1-L 
mRNA in the mammary gland, we first analyzed its expression profile in both 
proliferating and differentiated cells. We found that HuR expression levels 
significantly increased as measured by qPCR and Western Blot (Figures 6C and 6D, 
respectively). We also determined that the levels of HuR mRNA and Itgb1 protein 
correlated in mouse mammary samples as HuR mRNA and protein also peaked 
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during lactation (Figures 6E and 6F). These data suggested to us that HuR was likely 
to contribute to the slower decay of Itgb1-L mRNA in vivo. 
 
 
The AUBP HuR contributes to the stabilization of the Itgb1-L isoform 
 
To determine whether HuR binds to ARE sequences in the Itgb1-L 3’UTR, we 
evaluated the effect of HuR overexpression on the stability of a luciferase reporter 
mRNA containing the ARE1 and ARE2 sequences derived from the Itgb1-L isoform 
(see Figures 2D and 2E). Importantly, this construct included only the “differential 
region” between the Itgb1-L and the Itgb1-S (3’UTR-D) (Figure 7A). HeLa-TetOff 
cells were transfected with the LUC-3’UTR-D reporter construct under the control of 
a tetracycline responsive promoter (Tet-off) along with either a plasmid that 
expressed HuR or an empty vector. Cells were then incubated with tetracycline to 
selectively suppress reporter gene transcription and allow the assessment of mRNA 
stability. Luciferase expression was analyzed at different time points by qRT-PCR. 
Figure 7B shows that the luciferase mRNA fell to 50% after 4h when the reporter 
plasmid was co-transfected with an empty vector, while little mRNA decay was 
observed when HuR was co-expressed in the same cells. These results were consistent 
with HuR binding and stabilizing Itgb1-L mRNA through interactions with the AREs 
in the “D” region of the mRNA. To determine whether ARE1 in the Itgb1-L mRNA 
interacts with recombinant HuR protein or with endogenous HuR in mammary cells, 
RNA Electromobility Shift Assays (RNA EMSA) were performed. Figure 7C shows 
that a recombinant GST-HuR protein formed a complex with radiolabelled probe 
containing Itgb1-ARE1 sequences that migrated with decreased mobility relative to 
the free probe. Comparable bands were not formed after incubation of probes with 
GST protein alone. Proteins within HC11 cell lysates also formed complexes with the 
same probe and not with a labeled control probe with an antisense orientation. Protein 
binding to the ARE1 probe was competitively inhibited by an excess of unlabeled 
ARE1 probe. Preincubation of the HC11 lysates with a HuR antibody resulted in a 
further decrease in electrophoretic mobility (supershift) that was not observed after 
incubation with an antibody against GFP, suggesting the specific presence of HuR in 
the protein/probe complex. Protein extracts of mouse mammary glands at different 
developmental stages were incubated with the same probe and we observed a 
particular array of retarded bands that varied depending on the cell source (Figure 
7D). Specific bands that correspond in position with HuR containing complexes were 
present in all the samples. In addition, we proceeded to specificly knockdown HuR 
expression with siRNA in proliferating HC11 cells. This procedure reduced HuR 
mRNA and protein levels by 70% 3 days after transfection (Figure 7E and inset). This 
led to a significant reduction of remaining Itgb1-L mRNA endogenous species  3 h 
after the addition of the transcriptional inhibitor Actinomycin D (Figure 7F). 
Altogether the results in Figures 7B to 7F indicate that HuR is important for the 
stabilization of the Itgb1-L isoform in HC11 cells. 
The 3’UTR of the Itgb1-L isoform contains sequences that participate in 
regulation of translation efficiency 
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In addition to effects on mRNA stability, AUBPs bound to AREs are known 
to influence the translation of target mRNAs. We therefore determined whether the 
differential region in the 3’UTR of Itgb1-L could also modulate translation. To this 
end, we analyzed the translation efficiency of luciferase mRNAs under the control of 
a constitutive promoter and bearing different Itgb1 3’UTRs. HC11 cells were 
transfected either with a plasmid containing the Itgb1-S 3’UTR (3’UTR-S) or the 
3’UTR-D (shown in Figure 7A). Figure 7G (upper panel) shows that Luciferase 
activity (ie. protein level) was almost 4 times lower in cells transfected with the 
construct containing the 3’UTR-S compared to cells transfected with the Luciferase-
3’UTR-D reporter. Surprisingly, based on the predicted differences in mRNA stability 
from the earlier studies, luciferase mRNA levels, measured by qPCR, were similar 
with both constructs (data not shown). Based on the ratio of luciferase activity to 
luciferase mRNA (Figure 7G lower panel) this data suggests that the sequences only 
present in the 3’UTR of the Itgb1-L isoform, enhance the translational efficiency of 
the LUC gene. 

Discussion  
 
The development of multi-cellular organisms results, to a large extent, from 
changes in the pattern of gene expression within different constituent cells. These 
changes are the cellular response to environmental signals that are transduced into the 
cell and affect metabolism, transcription and translation among other biochemical 
processes. In addition to the more widely-studied mechanisms that control gene 
transcription, mechanisms of posttranscriptional RNA processing have increasingly 
been recognized as important participants in the regulation of gene expression [11, 
12]. Such mechanisms include: alternative splicing, regulation of mRNA stability and 
alternative 3’ end processing or polyadenylation [11, 12]. In the present study, we 
have identified two different mRNA transcripts encoding murine Itgb1 that result 
from differential cleavage and polyadenylation of the transcript. Posttranscriptional 
processing of Itgb1 transcripts results in a shorter isoform (Itgb1-S, 532 nt long 
3’UTR) than the one that had been previously-reported (Itgb1-L, 1100 nt long 
3’UTR). Here, we show that both isoforms are expressed by several mouse cell types, 
including epithelial cells from the mammary gland. In studies presented as 
supplementary data, 3’RACE PCR and sequence analysis of the human ȕ1-integrin 
revealed similar results to those obtained from the mouse, suggesting that this process 
is conserved from an evolutionary perspective (Supplementary Figure 2).  
 
There are several mechanisms by which two alternative mRNA variants can 
be expressed from a single gene. One of them is the differential usage of an 
alternative cleavage and polyadenylation (poly(A)) site. Sequence analysis of the 
Itgb1 3’UTR confirmed the existence of a potential poly(A) signal downstream from 
the stop codon, approximately half way to the previously-reported 3’ end. We 
validated its functionality in mammary epithelial cells using a reporter system [22]. 
This proximal poly(A) site displayed weaker activity compared to the strong 
polyadenylation signal from the control gene 77s.AE, although remarkably stronger 
than the control reporter or a mutated version of this same poly(A) site. Weaker 
activity of the proximal site in Itgb1 compared to the distal site is consistent with the 
observed percentage of usage observed in the analysis of tissue libraries.  
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Functionally, integrins connect living cells with the extracellular matrix, 
facilitating physical integration with the cellular entourage and signaling interactions. 
Specifically, Itgb1 expression is required for the maintenance of functional mammary 
stem cells, allowing mammary morphogenesis and segregation of the major mammary 
cell compartments [23, 24]. This protein is also required for mammary differentiation, 
since inhibition of alveologenesis and lactation were reported when conditional 
deletion of Itgb1 was induced by Cre recombinase expression in the luminal cell 
population [9, 10]. On the other hand, tissue microarray analysis of Itgb1 
protein expression in invasive breast cancer tissues revealed a trend toward high 
protein levels being indicative of poor prognosis [25]. These facts support the 
hypothesis that Itgb1 expression needs to be tightly controlled and finely tuned to 
allow differentiation and function of the mammary epithelium without facilitating 
cancer development. The data reported herein suggest that alternative cleavage and 
polyadenylation that let differential use of 3’UTR regions controlling mRNA stability 
and translatability might facilitate the precise control of Itbg1 protein levels in this 
tissue.  
 
  In this study, we report that the mammary gland expresses both Itgb1isoforms 
although in the lactating gland the levels of Itgb1-S decrease to become undetectable 
by RT-qPCR. Possibly, this reduction is associated to the relative transcription 
inhibition of Itgb1, among other genes as already reported [26], during lactation. 
However, as mentioned above, other authors and our own data have shown the 
necessity of Itgb1 protein expression for functional and morphological differentiation 
of the mammary epithelium. When transcription of this gene is low, stabilization of 
the more translatable Itgb1-L isoform would help to fulfill the protein requirement. 
Then, after weaning, there appears to be a higher activity of the alternative, proximal, 
poly(A) site, or a selective destabilization of the Itgb1-L isoform. The Itgb1-S isoform 
lacks two AU-rich sequence motifs (AREs) implicated in the regulation of mRNA 
stability and translation [21]. The presence of AREs in the differential segment 
suggested to us that Itgb1-L and Itgb1-S mRNA stability could be differently 
regulated and we found that Itgb1-L mRNA is more stable in differentiated than in 
proliferating HC11 cells while Itgb1-S stability was similar under both conditions. In 
addition, we determined that the differential 3’UTR segment (3’UTR-D) only present 
in the Itgb1-L isoform confers instability to an engineered luciferase reporter 
construct. These data suggest that, during lactogenic differentiation, the mammary 
cell environment could induce stabilization of the otherwise unstable Itgb1-L isoform, 
probably through the selective expression of specific ARE binding proteins, 
collectively known as AUBPs.  
 
Our results indicate that HuR, which has been described to have a stabilizing 
role on bound mRNAs [21], would be at least one of the AUBPs involved in the 
regulation of Itgb1 mRNA stability in the mammary gland. We have found that HuR 
protein and mRNA expression profile in this tissue is consistent with the stabilization 
of endogenous Itgb1-L mRNAs during pregnancy and lactation. In addition, HuR 
over-expression increases mRNA stability to a reporter transcript containing the Itgb1 
3’UTR distal region and HuR knockdown using siRNA in proliferating HC11 cells 
decreases the stability of Itgb1-L mRNA HuR protein effectively binds a radiolabeled 
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probe that contains approximately 100 bases from Itgb1-L 3’UTR. Interestingly, it has 
been already reported that Itgb1 is a HuR target in T cells [27]. Our mobility shift 
assays also show that HuR-mRNA interactions exist in every stage of mammary 
gland development. However, the observed bands differ substantially from one stage 
to another, suggesting that HuR may be part of different specific protein complexes 
with a dynamic composition along the timeline of mammary gland differentiation and 
remodeling. Therefore, the reported HuR necessity for maintaining mammary cell 
proliferation and polarity [28] might be at least partially due to Itgb1-L stabilization.
Here, we also show that basal levels of Itgb1 protein are required to form normal 
mammary acini in 3D cultures. When expression of the Itgb1-L isoform is blocked, 
spontaneous induction of Itb1-S mRNA species would allow some expression of the 
Itgb1 protein and normal development of the acini is achieved (see Figure 5). On the 
other hand, in the lactating epithelium in which transcription of Itgb1 gene is 
somehow restricted and Itgb1-S levels are undetectable (see Figure 4), Itgb1 protein 
expression would be maintained by stabilization (see Figure 6A) and efficient 
translation (see Figure 7G) of the Itgb1-L mRNA isoform.
 
 
In addition to AUBPs, different studies have shown that Itgb1 is targeted by a 
number of distinct miRNAs including miR-29 [29], miR-183 [30] and miR-124 [31] 
that directly regulate its expression. Interestingly, miR-183 and miR-29 binding sites 
are present exclusively in the Itgb1-L isoform. In the mammary gland, low relative 
expression of miR-29 has been reported during lactation and high expression during 
late involution [32], correlating inversely with the expression levels of Itgb1-L as 
shown here and supporting a role for miR-29 in the degradation of the Itgb1-L mRNA 
isoform. Antagonism between HuR and miRNAs that promote mRNA decay (such as 
miR-16), have been reported for the regulation of COX-2 mRNA levels [33]. Future 
studies should address whether an analogous relationship links miR-29 and HuR at 
the Itgb1-L mRNA. Interestingly, miR recognition sites are conserved in human Itgb1 
3’UTR (Supplementary Figure 3) supporting their relevance in the expression 
regulation of this gene in multiple mammalian species.  
 
It has only been recently appreciated that more than half of the genes in the 
human genome are alternatively polyadenylated [34]. The relationship between 
signals that change the cell commitment, the corresponding signaling pathways and 
activity of gene promoters has already been well documented. In addition, solid links 
have been established for promoter activity and RNA processing events [35]. In 
particular, it has been shown that the regulation of poly(A) site choice is coupled to 
transcriptional activity and results in preferential expression of long 3’UTR isoforms 
when gene expression is low and short 3’UTR isoforms when gene expression is high 
[36]. As shown here, poly(A) site choice for Itgb1 might contribute to the “fine-
tuning” of gene expression with developmental consequences [37]. A deeper 
understanding of alternative polyadenylation as a mechanism for transcript diversity 
and concomitant gene expression regulation with biological consequences is 
warranted and the data presented here regarding Itgb1 in the mammary gland provides 
a relevant model with which those studies could be pursued.  
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To precisely regulate gene expression, achieve tissue remodeling and 
successful development, different cells must develop the ability to selectively respond 
to signals such as growth factors, hormones and/or ECM ligands in a timely manner. 
Itgb1 plays a critical role in the relationship of cells with the extracellular matrix and 
its expression must therefore be tightly regulated. In summary, our study strongly 
suggests that alternative mRNA polyadenylation represents one important mechanism 
through which cell type and tissue-specific gene regulation is achieved for this gene. 
Two different Itgb1 3’-isoforms produced by selective utilization of the first or 
second PAS and poly(A) sites are reported here for the first time. These alternative 
mRNA isoforms appear to provide a mechanism to control Itgb1 expression through 
differential regulation of stability and translation efficiency that can be finely tuned 
during mammary gland development. 

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Figure legends 
Figure 1. Genomic structures and expression of the mouse integrin ȕ1 gene analized 
using EST and SAGE databases. (A) Schematic representation of the mouse Itgb1 
3’UTR region. Two hundred and eighty three mouse Itgb1 3'-reads EST ends 
(Unigene Mm.263396) were mapped on the 3’UTR region, its analysis identified two 
transcript variants (cluster 1 and cluster 2) corresponding to two polyadenylation 
sites. (B) Tissue-specific expression of both Itgb1 variants (Itgb1-S and Itgb1-L) 
among 10 different mouse tissues according to the EST data.  (C) Hierarchical 
clustering analysis of Itgb1 variants expressed in different mouse tissues as indicated 
below based on the analysis of 269 mSAGE libraries available at SAGEgenie 
database. The grayscale at the bottom of the picture is used to represent relative 
expression level based on numbers of transcripts (tags) per libraries. The values range 
from 0 (white) to 180 (black). The position of tissue specific libraries in the cluster is 
indicated as R: Retina, B: Brain, MG: Mammary Gland, U: Urogenital tract, VE: 
Vascular Endothelium. 
Figure 2. Identification of the 3’UTR-differential Itgb1 mRNA isoforms. (A) 
Schematic representation of the Itgb1 gene of BALB/c mice (NCBI: GenBank 
accession no. NM_010578.2). The start codon is located in exon 1 and the stop codon 
is in exon 17. Grey boxes are 5´ and 3’UTR regions, the latter including polyA 
sequences (PAS1 and PAS2) and cleavage and polyadenylation sites (pA1 and pA2, 
arrows). Black boxes denote exons and lines, introns. The graph is not shown to scale. 
(B) Schematic representation of the cloning and sequencing protocol. (C) Analysis of 
3’RACE PCR products by electrophoresis in an EtBr-stained agarose gel identifies 
two species of Itgb1 messenger RNAs with 3’UTRs of different length (long, 1400bp 
and short, 750bp) indicated by arrows. RNA was obtained from BALB/c female mice 
normal mammary glands (NMG), either virgins in estrum (V) or lactating (L) and 4 
mammary tumors from independent in vivo tumor lines (1, 2, 3 and 4) induced by 
mouse mammary tumor virus MMTV. (D) Sequence of Itgb1 3’UTR showing the two 
PAS sequences (bold underlined), the 2 ARE sequences (grey boxes and bold) and 
primers (arrows) used for Real time PCR. Exonic sequences shown in “italic bold” 
font. (E) Diagram showing the two Itgb1 isoforms with differences at the 3’UTR, 
polyadenylation signals (PAS1 and PAS2, dark grey bars), sites of cleavage and 
polyadenylation (pA1 and pA2, vertical arrows), ARE regions (white bars) and 
location of the primers for the qPCRs (horizontal arrows). 
Figure 3. Cleavage and Polyadenylation activity directed by the Itgb1 polyA site 1 
(pA1). (A) Diagram showing relevant features of the pRiG vector. pCMV, human 
cytomegalovirus (CMV) immediate early promoter; RFP, coding region for red 
fluorescent protein; MCS, multiple cloning sites; IRES, internal ribosome entry site; 
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EGFP, coding region for enhanced green fluorescent protein;  77S.AE, 77S.AE 
polyadenylation site and Itgb1.pA1, Itgb1 polyadenylation site 1 in its wild type and 
mutated versions, the core sequences of the cloned fragments are shown in detail. (B) 
FACS analysis of HC11 cells transfected with different pRiG vectors, as indicated 
above each graph. pRiG: pRiG empty vector; pRiG-77S.AE: pRiG vector with an 
77S.AE polyA site sequence inserted in the MCS; pRiG-Itgb1.pA1: pRiG vector with 
a sequence containing the region surrounding PAS1 of mouse Itgb1 inserted in the 
MCS, pRiG-Itgb1.pA1mut: pRiG vector with a mutated sequence containing the 
region surrounding PAS1 of mouse Itgb1 inserted in the MCS. The intensity of red 
fluorescence (y-axis) and the intensity of green fluorescence (x-axis) were read as 
indicated in Materials and Methods. Each dot represents a cell. One representative 
experiment out of four performed is shown. Cumulative fraction curves of ratio of 
green fluorescence to red fluorescence for cells are shown (lower graph). Only cells 
with red fluorescence intensity higher than background were selected for analysis.  
(C) Quantitative measurement of the ratio of red to green fluorescence as read in the 
upper-left and lower-right quadrants respectively, calculated as the average of four 
different experiments. # p<0,05 One-way ANOVA, followed by a Tukey post-test. 
Figure 4. Relative expression of different Itgb1 mRNA species during normal 
mammary gland development. (A) Itgb1 and Actin protein levels from mammary 
glands (NMG) of virgin, pregnant, lactating and post-involution (INV 72h) female 
mice were analyzed by Western blot and quantified by the image J programme 
calculated as the average of three different experiments. # p<0,05 One-way ANOVA, 
followed by a Tukey post-test. (B) Total Itgb1 mRNAs levels were determined in the 
same RNA samples by quantitative RT-PCR (qPCR). # p<0,05 One-way ANOVA, 
followed by a Tukey post-test. (C) The expression of the isoforms of the mRNA of 
Itgb1, Itgb1-L (white columns) and Itgb1-S (black columns) mRNAs levels were 
determined in the same RNA samples by qPCR. (D) qPCR assays for Itgb1 mRNA 
isoforms short and long (Itgb1-S, black columns and Itgb1-L, white columns) present 
in progressive post-involution mammary glands (INV 24h, 48h and 72h).* p<0,05 
Student t-test. (E) Same as in (D) using HC11 cells subject to mechanical stretching 
as a source of RNA. Gapdh mRNA was used as normalization control in all the 
qPCRs.* p<0,05 Student t-test. 
Figure 5. Biological relevance of the Itgb1-S mRNA isoform. (A) Western blot 
analysis of protein extracts from HC11 cell lines transfected with diferent ShRNAs 
plasmids and selected by antibody resistance: ShRNA control or scramble (Shctrl), 
ShRNA against Itgb1-T mRNA (ShItgb1-T), and  ShRNA against Itgb1-L mRNA 
(ShItgb1-L). Itgb1, Cyclin D1 and Actin antibodies were evaluated. (B) qPCR assays 
to measure the levels of Itgb1 mRNA isoforms in cell lines that express the different 
shRNAs indicated. # p<0,05 One-way ANOVA, followed by a Tukey post-test. (C) 
3D cultures of HC11 cell lines were achieved by seeding cells in Matrigel coated 
plates. Representative optic  microscope images of are shown 
Figure 6. Endogenous expression of Itgb1 isoforms during differentiation of HC11 
cells.  (A) and (B) Representative experiments of mRNA stability assays performed 
three times independently. HC11 cells were cultured under proliferative and 
differentiation conditions. Actinomycin D (5ug/ul) was added (t = 0), and mRNA 
levels of Itgb1 mRNA isoforms were analized by qPCR following a time course 
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(hours). Samples corresponding to cells proliferating or differentiated are depicted 
with dashed lines and continuous lines respectively. Primers directed to detect the 
Itgb1-L isoform (A) or the Itgb1-S isoform (B) were used. Gapdh mRNA was used as 
normalization control. (C) Expression of HuR mRNA in HC11 cells under 
proliferative and differentiation conditions as shown by qPCR analysis. Gapdh 
mRNA was used as normalization control.* p<0,05 Student t-test. (D) HuR protein 
expression levels in the same samples. (E) Levels of HuR mRNA expression were 
measured by qPCR using RNA from normal mammary glands (NMG) of female mice 
virgins in estrum (V), pregnant (P), lactating (L) or post-involution (INV 72h). * 
p<0,05 Student t-test. (F) HuR and Actin protein levels were analyzed by Western 
blot in the same samples. 
Figure 7. (A) Diagram showing part of the last exon (# 17) corresponding to the 
3’UTR of the Itgb1 gene. Different segments were cloned downstream of a luciferase 
reporter gene (black box) driven by a constitutive promoter or under the control of a 
Tetracycline responsive promoter (Tet-off) (not shown). Two reporter constructs were 
generated: “3’UTR Short” includes a segment corresponding to the short form of the 
Itgb1 mRNA and “3’ UTR D” includes the differential segment. Numbers 29, 124 and 
183 indicate binding sequences for miRNAs. White bars indicate ARE sequences and 
arrows sites of cleavage and polyadenylation that produce both mRNA forms: Itgb1-L 
and Itgb1-S preceded by 2 alternative polyadenylation signals (PAS1 y PAS2) 
indicated by dark grey bars. (B) mRNA stability assay from cells transfected with a 
reporter plasmid containing the “3’ UTR D” cloned downstream of the Luciferase 
open reading frame under the control of a Tetracycline responsive promoter (Tet-off). 
Cells were co-transfected with a HuR expression vector (solid line) or with empty 
plasmid (dashed line).# p<0,05 One-way ANOVA, followed by a Tukey post-test. (C) 
A radiolabeled probe containing the Itgb1 ARE1 sequence (100-nt probe) was 
incubated with 5-7 ug of HC11 protein lysate and mobility shift assays were carried 
out. Antibodies, recombinant proteins and unlabeled probes were added to the mixture 
before the addition of the labelled probe as indicated. (D) The Itgb1 ARE1 100-nt 
probe was incubated with 5-7 ug of protein lysate from normal mammary glands at 
different developmental stages as indicated: BALB/c female mice virgins in estrum 
(V), pregnant (P), lactating (L) or 72 hs post-involution (I72). Bands “a” to “c” denote 
representative shifted complexes and horizontal arrows indicate the HuR antibody 
super-shifted position. (E) HC11 cells were transfected with SiRNA control (Si 
control) or SiRNA HuR (Si HuR). Western blots (inset) and qPCR  were performed in 
order to measure the levels of expression of HuR protein and mRNA respectively. * 
p<0,05 Student t-test. (F) HC11 cells were transfected with the same SiRNAs and 
cultured under proliferative conditions.  Actinomycin D (5ug/ul) was added (t = 0) 
and  mRNA levels of Itgb1-L mRNA isoform was analized by qPCR following a time 
course (3hours). Samples corresponding to cells tranfected with Si control or Si HuR 
are depicted with dashed lines and continuous lines respectively. * p<0,05 Student t-
test. (G) Luciferase activity measured in HC11 cells transfected by the indicated 
reporter constructs driven by a constitutive promoter as measured by a luminometer.* 
p<0,01 Student t-test. Luciferase activity values were normalized to the corresponding 
mRNA levels to obtain translation efficiencies. 
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